📊 Score Breakdown
Offering Ability
20
Cash Runway
25
Float Risk
25
Warrant Exposure
70
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
54%
🔁 Convertible Conversion
60%
• Major convertible overhang: 138% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
55%
• 50-day avg $0.61 below $1 exchange minimum
📜 Warrant Exercise
40%
• Significant warrants: 23% of shares outstanding
• Elevated warrant risk score (70/100)
💹 Market Data
Market Cap$24.96M
Shares Outstanding39.62M
Float34.38M
Cash$61.77M
Debt$1.43M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 33.6% shares (2025Q4 vs prior)
59 institutional holders · 16.39M shares
#1
ORBIMED ADVISORS LLC
3.11M shares
#2
TCG Crossover Management, LLC
2.68M shares
#3
VANGUARD GROUP INC
1.82M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.80M
Days to Cover1.6
% of Float5.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jul 31, 2025
xbrl
XBRL CONVERTIBLE
Mar 31, 2017
8-K
8K EVENT
Apr 13, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VTGN
📊 VTGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VTGN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.